KAYS
Kaya Holdings, Inc.0.0440
+0.0114+35%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
30.20MP/E (TTM)
-Basic EPS (TTM)
-0.10Dividend Yield
0%Recent Filings
8-K
Appoints veteran attorney to board
Kaya Holdings appointed Richard D. Seay, a 72-year-old attorney with 47 years in Florida courts and public company experience, to its board effective November 25, 2025. Board cites his expertise in securities, corporate law, and litigation as a key addition. He's run his own Fort Lauderdale firm for five years. No compensation disclosed.
10-Q
Q3 FY2025 results
Kaya Holdings posted Q3 revenue of $5,408, up sharply y/y from $3,000, with gross profit at $5,370; yet operating loss hit $269,010 amid $274,380 expenses, while net loss exploded to $8.6M from $2.4M y/y due to $7.8M change in derivative liabilities from debt conversions. Nine-month revenue climbed to $22,557 (y/y +652%, derived), but net loss reached $12.7M versus $3.0M prior, driven by $11.0M derivative swings exceeding operating loss by >20% from fair-value changes and interest. Cash dipped to $26K; debt slashed to $521K convertible notes (due 2026) plus $59K notes, with $504K derivatives. Sold MJAI cannabis license for $75K gain. Section 280E lingers from past cannabis ops.
8-K
Debt-to-equity swap hands control
Kaya Holdings converted $13.98M of debt—over 90% of its total—into 642.9M shares on October 21, 2025, handing CVC International 56.19% voting control and triggering a change in control. This cleans the balance sheet to fuel its crypto subsidiary and digital assets treasury pivot via talks with foundations on Solana, Ethereum, or Polygon networks. CVC dominates now. DATCO success hinges on joint ventures.
10-Q
Q2 FY2025 results
Kaya Holdings posted Q2 revenue of $10,097, up from zero a year ago (derived), with gross profit at $3,362 on $6,735 cost of sales, but operating loss widened to $162,584 from $340,573 as psychedelic treatment ops ramped via The Sacred Mushroom facility. Net loss hit $2,609,336, versus prior profit of $415,873, driven by $2.2M change in derivative liabilities expense from new convertible notes while operating loss trailed net by >20% due to interest, debt discount amortization, and derivatives per statements. Cash ticked to $48K; $75K escrow receivable awaits OLCC approval for MJAI license sale. Derivative volatility looms large.
10-Q
Q1 FY2025 results
Kaya Holdings posted first revenue from continuing operations at $7,052 for Q1 ended March 31, 2025, up from zero a year ago, with gross profit of $2,082 on $4,970 cost of sales—yet operating loss widened to $309,538 from $238,830 y/y amid higher professional fees and salaries for the psychedelic shift. Net loss hit $1,636,770, or $(0.04) per diluted share on 42.7M shares, versus $1,085K last year, driven by $1.0M change in derivative liabilities and $140K debt discount amortization while interest edged up 9.5% to $197K. Cash climbed to $50,718 on $195K new convertible notes, but $9.6M working capital deficit persists alongside $9.2M convertibles due 2026. Debt overhang looms large.
IPO
Website
Employees
Sector
Industry
AAWH
Ascend Wellness Holdings, Inc.
0.99+0.21
AYRWF
AYR WELLNESS INC.
0.03+0.01
CBSTF
THE CANNABIST COMPANY HOLDINGS
0.10+0.03
CRLBF
Cresco Labs Inc.
1.75+0.45
CURLF
Curaleaf Holdings, Inc.
4.53+0.85
JUSHF
Jushi Holdings Inc.
0.84+0.11
MSTH
Mystic Holdings Inc.
0.01+0.00
PLSH
Panacea Life Sciences Holdings,
0.09+0.00
TLRY
Tilray Brands, Inc.
13.94+3.01
YCBD
cbdMD, Inc.
1.43+0.23